sub field
BiotechDrug DiscoveryLongevity
stage
Startup
About
Sebastian A. Brunemeier is a longevity-focused biotech investor and company builder. As of April 30, 2026, he is publicly listed as General Partner at Healthspan Capital, Co-Managing Partner at LongGame, and founder/CEO of ImmuneAGE Bio; previously he was Principal at Apollo Health Ventures and co-founder/CIO of Cambrian Biopharma. His work centers on longevity biotech, regenerative medicine, and therapies targeting the biology of aging.
Areas of interest
longevityaging biologybiotechregenerative medicinedrug discoverygene therapyprotein engineeringimmunologygerosciencenatural productscompany buildinglongevity clinical services